acid-base disorder/ccm board review

8/10/2019 Acid-Base Disorder/CCM Board review

http://slidepdf.com/reader/full/acid-base-disorderccm-board-review 1/59

!""#$%&' )$ !&*+,-%./

0*.$#+/#.

1%#$2+ 34 56/#2*"7 30 8!9:7 899:7 8!5;7 8;<8

=>*?/#.*)@ $A ;$#)' B/C%. 1/%2)' 5&*/>&/ 9/>)/#



8%&D2)@ 0*.&2$.D#/.

• "#$%& '())*#&+ '),-&#$. /0$1%*23-24 5.0 60..7



E/%#>*>F GHI/&J?/.

89,# &:02 2,220*%4 .,$#%,#2 ;0.. <, $<., &*=

>? @,-*1%0A, $ 20B)., $-0CD<$2, C02&(#<$%-,

E? @,-*1%0A, $ B0F,C $-0CD<$2, C02&(#<$%-,



!""#$%&' )$ !&*+,-%./

• G,%C,#2*%DG$22,.<$.-: HI*2&*%?

• '&#*%1DJ*% /0K,#,%-, H'&,;$#&?

• I$2,D,F-,22 HL*),%:$1,%?

• 8.&:*(1: ,$-: $))#*$-: :$2 0&2 )#*2 $%C -*%24

<,-$(2, *M 0&2 ,$2, *M (2,4 &:, &#$C03*%$. G,%C,#2*% D

G$22,.<$.-: $))#*$-: ;0.. <, (2,CN



3KB!-GEL9 !9L0G5L5

G,%C,#2*% ,O($3*%

PGQR S T C HPGELUVRWPGLUVDR?

PGQR S EX

G$22,.<$.-: B*C0Y-$3*%

)G S )T C .*1ZPGLUVDRW P'LUE F [LUER\

[LUE

GLUVD pH 7.5 [H+] = 30

pH 7.4 [H+] = 40

pH 7.3 [H+] = 50



!""#$%&' )$ !&*+,-%./

)G S )T Q .*1ZPGLUVDRW P'LUE F [LUER\

)G S T$ Q 6*1

/*,2 %*& B,$% &:$& )G 02 ):720-$..7 C,&,#B0%,C <7

GLUV $%C [LUE

[#*]0C,2 M$.2, 0B)#,220*% &:$& &:, <(K,# )$0# +

PGLUVDRWPGELUVR 02 B*#, 0B)*#&$%& &:$% *&:,# <(K,#2

'(11,2&2 &:$& PGLUVR 02 $% 0%C,),%C,%& ]$#0$<.,

G,%C,#2*% G$22,.<$.-: ,O($3*%

GLUVD

^N^V F [LUE{Buffer-Base Pair}



!""#$%&' )$ !&*+,-%./

!

/* G02&*#7 $%C [:720-$.

! _,$2(#, )G4 [LUE4 GLUV H`I" *# 8I"?

! L$.-(.$&, 8%0*% "$) HL*##,-& M*# 8.<(B0%?

! 8)).7 L*B),%2$3*% #(.,2

"

5F-,)& M*# L:#*%0- #,2)0#$&*#7 $.a$.*202 -*B),%2$3*% %,],#-*##,-&2 &* %*#B$.

" JM -*B),%2$3*% 02 &** B(-: *# &** .0b.,4 &:,#, 02 $ 2,-*%C)#0B$#7 C02&(#<$%-,

" c:,% 0% C*(<& (2, $-0CD<$2, B$)

!

L$.-(.$&,

C,.&$WC,.&$



!""#$%&' )$ !&*+,-%./

•

G02&*#7 $%C [:720-$. L.(,2>N `*B03%1 + B,&$<*.0- $.a$.*202

EN G02&*#7 *M /0$<,&,2 + B,&$<*.0- $-0C*202

VN G02&*#7 2B*a0%1WLU[/ + #,2)0#$&*#7 $-0C*202

XN

G02&*#7 *M 60],# C02,$2, + #,2)0#$&*#7 $.a$.*202

dN @,-,%& <0%1, C#0%a0%1 + B,&$<*.0- $-0C*202

eN /0$##:,$ + B,&$<*.0- $-0C*202

fN

g$-:7)%,$ + #,2)0#$&*#7 $.a$.*202

hN

G7)*&,%20*% + B,&$<*.0- $-0C*202



!""#$%&' )$ !&*+,-%./

_,:&$ 8c4 5BB,b _N 8))#*$-: &* $-0CD<$2, C02*#C,#2N J% [#0B,# *% T0C%,7/02,$2,2N Hd&: ,C03*%? "#,,%<,#1 8 H 5C?N '$(%C,#2 5.2,]0,#4 [:0.$C,.):0$4 E^^i



!""#$%&' )$ !&*+,-%./

_,:&$ 8c4 5BB,b _N 8))#*$-: &* $-0CD<$2, C02*#C,#2N J% [#0B,# *% T0C%,7/02,$2,2N Hd&: ,C03*%? "#,,%<,#1 8 H 5C?N '$(%C,#2 5.2,]0,#4 [:0.$C,.):0$4 E^^i

8.a$.,B0$ H)G j fNXd?



Na140

Cl105

HCO3

10

unmeasured anions

(Proteins, SO4, PO4,

organic anions)

unmeasured

cations

(K, Ca, Mg){

Na140

HCO3

10

Cl120

}

}Lactate

15

Anion

Gap

10Anion

Gap25

Anion GapAcidosis

HyperchloremicAcidosis

Normal

Gap 10

Normal

Gap 10

!""#$%&' )$ !&*+,H%./M !>*$>,F%"



!""#$%&' )$ !&*+,-%./

!>*$>,N%"

• 8"S k$Q D HGLUVD Q L.D?

• k*#B$. 8" >^ l E

• L*##,-& M*# $.<(B0%

•

m*# ,],#7 > 1BWC. C,-#,$2, $CC ENd B,O &* 8"

8"-*# S k$Q D HGLUVD Q L.D? Q HX + 8.<?ENd



!""#$%&' )$ !&*+,-%./

• L*B),%2$3*% #(.,2

– _,&$<*.0- 8-0C*202

• :9G

O P Q4RS19G

TU V W X O

• [LUE S .$2& E C010&2 )G

•

[LUE S GLUV Q >d

–

_,&$<*.0- 8.a$.*202•

[LUE n <7 ^NdD^Nf M*# ,$-: > B,O n

GLUV H(2($..7 %*& jddDe^?



!""#$%&' )$ !&*+,-%./• L*B),%2$3*% #(.,2

–

@,2)0#$&*#7 8-0C*202• 8-(&, DD > B,O n 0% GLUV M*# ,],#7 >^ BBG"

n[LUE

• L:#*%0- + VNd B,O n 0% GLU

V

M*# ,],#7 >^

BBG" n[LUE

– @,2)0#$&*#7 8.a$.*202

• 8-(&, DD E B,O o 0% GLUV M*# ,],#7 >^ BBG"

o 0% [LUE

• L:#*%0- DD d B,O o 0% GLUV M*# ,],#7 >^ BBG"

o 0%[LUE



!""#$%&' )$ !&*+,-%./

• /,.&$D/,.&$ H!1$)W!GLUVD?

# 822(B0%1 &:$& &:, GQ 2)$-, 02 ,O(0]$.,%& &* &:,

GLUVD 2)$-,

#

g:$% M*# ,],#7 > B,O 0%-#,$2, 0% &:, 8" &:,#, 2:*(.C

<, $ ,O($. C,-#,$2, 0% &:, GLUVD

!&)D%2 !>*$> N%" Y ;2 !>*$> N%"

;2 19GT, , !&)D%2 19GT

, P Q



!""#$%&' )$ !&*+,-%./

• /,.&$D/,.&$ H!1$)W!GLUVD?

•

JM 1#,$&,# &:$% > &:$% &:,#, 02 $ -*%-(##,%& B,&$<*.0- $.a$.*202

•

JM .,22 &:$% > &:$% &:,#, 02 $ -*%-(##,%& :7),#-:.*#,B0-

B,&$<*.0- $-0C*202

!&)D%2 !>*$> N%" Y ;2 !>*$> N%"

;2 19GT, , !&)D%2 19GT, S >



!""#$%&' )$ !&*+,-%./M

5*Z"2/ 3/)%H$2*& !&*+$.*.

8%0*% "$) G7),#-:.*#,B0-

_,&$<*.0- 8-0C*202



!""#$%&' )$ !&*+,-%./M

!>*$> N%" 3/)%H$2*& !&*+$.*.

M ethanol U remia

D iabetic or alcoholic ketoacidosis/ Drugs

P henformin/Paraldehyde/Pyroglutamic Acid/Propylene Glycol

I nh/Iron

L actic acidosis ( L & D )

E thylene glycol S alicylate



!""#$%&' )$ !&*+,-%./M

!>*$> N%" 3/)%H$2*& !&*+$.*.

G lycols O xoproline

L - lactic acidosis

D - lactic acidosis

M ethanol

A spirin

R enal failure K etoacidosis



E%&J& !&*+$.*.

6$-3- 8-0C*202$ 6$-&$&, j d BB*.W6

$

)G p fNVd

$ 8%0*% 1$) 0%2,%203],

$ 822*-0$&,C ;0&: $ ;*#2, )#*1%*202

H,2),-0$..7 ;:,% %*& #$)0C.7 -.,$#,C?



E%&J& !&*+$.*.

E%&J& !&*+$.*.

B@"/ !

L>%+/[D%)/ J..D/ $C@F/>%J$>

B@"/ -

!+/[D%)/ J..D/ $C@F/>%J$>

B'/#/ *. $\/> %> $?/#2%"

J%-#,$2,C .$-&$&, )#*C(-3*%

C,-#,$2,C .$-&$&, (3.0A$3*%



E%&J& !&*+$.*.

• Etiology of Lactic Acidosis

• Drugs

$ biquanides$ nucleoside analogs

$

propylene glycol$

propofol

$ !-agonists

$ linezolid$ aspirin

$

cocaine



E%&J& !&*+$.*.M

:#$"@2/>/ N2@&$2

Q,O "#$"%>/+*$2

G UG GUG D L D L D L D G

G G G

d^q (%-:$%1,C

8.-*:*.

C,:7C*1,%$2,

E%&)%)/



E%&J& !&*+$.*.M

:#$"@2/>/ F2@&$2

:#$"@2/>/ N2@&$2

% 9$ZZ$> ?/'*&2/ A$# >DZ/#$D. +#DF.

$

6*#$A,)$B4$ /0$A,)$B4

$ k0&#*1.7-,#0%

$ [:,%7&*0%

$

5&*B0C$&,$ g#0B,&:*)#0BD2(.M$B,&:*F$A*.,

$ '0.],# 2(.M$C0$A0%,

L.(,=

U2B*.$. 1$)



!>*$> N%" !&*+$.*.

E$] 3$2/&D2%# ^/*F') !2&$'$2.

•

_,&$<*.0- $-0C*202

• U2B*.$. 1$) H B,$2(#,C *2B*.$.0&7 D -$.-(.$&,C *2B*.$.0&7r j

>^?

* calculated osmolality = 2 x Na + BUN/2.8 + Glucose/18 + ethanol/4.6

Time&



!>*$> N%" !&*+$.*.

E$] 3$2/&D2%# ^/*F') !2&$'$2.

•

5&:7.,%, 1.7-*.& *F$.0- $-0C

• /,-#,$2,C _'

•

@,%$. m$0.(#,

•

UF$.$&, -#72&$.2

• _,&:$%*.& M*#B0- $-0C

•

/,-#,$2,C _'

•

`02($. C02&(#<$%-,2 H)$)0..032?

Acidosis secondary to the metabolism of

alcohol by alcohol dehydrogenase



!>*$> F%" %&*+$.*.M )#/%)Z/>)

>N

g#,$& (%C,#.70%1 -$(2,

EN @,).$-, I(K,# H-*%&#*],#20$.?

VN G,B*C0$.7202



!>*$> N%" !&*+$.*.

E$] 3$2/&D2%# ^/*F') !2&$'$2.

•

g#,$&B,%&=

• 8.-*:*. *# M*B,)0A*., !"#$%&'& )#* +,"#-#, .&-/.*#0&1+2&3

• /0$.7202



G7),#-:.*#,B0- _,&$<*.0- 8-0C*202

Renal Non-Renal

Decreasedrenal NH4+

excretion

= * ! * N



Na50

Cl

135

kGX

fd

U&:,#

$%0*%2

T

Xd

Na

50

Cl

80

kGXE^ U&:,#$%0*%2

T

Xd

Normal NH4

excretion

Decreased NH4

excretion

N e g a t i v e

ani on

g a p

p o si t i v e

ani on

g a p

=#*>/ !>*$> N%"s#0%, $%0*% F%" Hs k$ Q sT? + s-.

J%C0#,-& B,$2(#, *M (#0%, kGX

Q



5F-#,3*%*M

*#1$%0- $%0*%2

/,M,-& 0%GLUV

D

#,-.$B$3*%

/,M,-& 0%GQ

2,-#,3*%

J%$C,O($&,kGV

)#*C(-3*%

5F&#$D#,%$.6*22 *M <$2,

8-0C .*$C

g*.(,%, 0%1,23*%/0$<,3- a,&*$-0C*202

[#*F0B$. @g8 /02&$. @g8@,%$. M$0.(#,

G7)*$.C*2&,#*%02B[G8

/0$##:,$[$%-#,$3- Y2&(.$

s#,&,#$. C0],#20*%2

kGXL.WGL6k$L..*$C

Fractional

Excretion

HCO3 >15%

Urine pH > 5.5

Positive Urine AG Negative

Urine AG

Urine pH < 5.5

(pH maybe > 5.5)

Positive Urine AG

High urine osmole gap

1@"/#&'2$#/Z*& 3/)%H$2*& !&*+$.*.



3/)%H$2*& !2_%2$.*.

•

",%,#$3*% [:$2,

– 6*22 *M GQ *# 1$0% *M <$2,

• _$0%&,%$%-, [:$2,

–

/,-#,$2, #,%$. GLUVD ,F-#,3*%

• /,-#,$2,C "m@

• `*.(B, C,).,3*%

• G7),#$.C*2&,#*%02B

•

/,-#,$2,C L:.*#0C,

•

G7)*a$.,B0$



3/)%H$2*& !2_%2$.*.

L:.*#0C, #,2)*%20], L:.*#0C, @,202&$%&

m,L. p >q

`*B03%1

/0(#,202

m,L. j >q

G7),#$.C*2&,#*%02B

G7)*a$.,B0$



3/)%H$2*& !2_%2$.*.

•

g#,$&B,%&

– L:.*#0C, #,).,3*%

– [*&$220(B #,).,3*%

–

')0#*%*.$-&*%,W,).,#,%*%, –

8-,&$A*.$B0C,

–

^N> k GL6



`/."*#%)$#@ !&*+$.*.

•

/,-#,$2,C ],%3.$3*%

– L,%&#$. H%$#-*3-2?

– L:,2& c$.. H)$0%?

–

/0$):#$1B H B7*)$&:7? –

J%-#,$2,C C,$C 2)$-,



`/."*#%)$#@ !2_%2$.*.

•

J%-#,$2,C ],%3.$3*%

– L,%&#$.

– ',)202

–

'$.0-7.$&,2 –

[#,1%$%-7

–

60],# C02,$2,

–

G7)*F0$



3*C/+ !&*+,-%./ 0*.$#+/#.

•

c:,% &* 2(2),-&

>N )G %*#B$. ;0&: $<%*#B$. [LUE *# GLUV

EN 8-0C,B0$ ;0&: .*; GLUE :01: [LUE

VN

/,.&$=/,.&$ j >NEXN

8.a$.,B0$ ;0&: :01: GLUV $%C .*; [LUE

dN

L*B),%2$3*% %*& $))#*)#0$&,



9%./ Q

•

8 dED7,$#D*.C B$% 02 $CB0b,C &* &:, 0%&,%20], -$#, (%0&;0&: )%,(B*%0$ $%C 2,)3- 2:*-aN U],# &:, )$2& X C$724 :,:$2 :$C 0%-#,$20%1 2:*#&%,22 *M <#,$&: $%C M,],#N G, :$2:7),#&,%20*%N _,C0-$3*%2 $#, $B.*C0)0%, $%C

:7C#*-:.*#*&:0$A0C,N• U% ):720-$. ,F$B0%$3*%4 &,B),#$&(#, 02 VhNh L4 )(.2, #$&,02 >>^WB0%4 #,2)0#$&*#7 #$&, 02 EEWB0%4 $%C <.**C )#,22(#, 02hdWd^ BB G1N L$#C0$- ,F$B0%$3*% #,],$.2 $ 1#$C, EWe

272&*.0- B(#B(#N U% )(.B*%$#7 ,F$B0%$3*%4 &:,#, $#,-#$-a.,2 *],# &:, ,%3#, #01:& .(%1 Y,.CN g:,#, 02 &#$-, ),C$.,C,B$N



9%./ Q

•

6$<*#$&*#7 '&(C0,2

• ".(-*2, >>d B1WC6

• I.**C (#,$ %0&#*1,% EE B1WC6 H

•

L#,$3%0%, >NX B1WC6• '*C0(B >Ve B,OW6

• [*&$220(B XNh B,OW6

• L:.*#0C, >^V B,OW6

•

I0-$#<*%$&, >> B,OW6• 8.<(B0% VNh 1WC6

• )G fN^ [LUE Xe BB G1 [UEd> BB G1



9%./ Q

•

c:0-: *M &:, M*..*;0%1 -*%C03*%2 02 B*2& .0a,.7 )#,2,%& 0%&:02 )$3,%&t

• 8N 8%0*% 1$) B,&$<*.0- $-0C*202

• IN _0F,C %*%+$%0*% 1$) B,&$<*.0- $-0C*202 $%C#,2)0#$&*#7 $-0C*202

• LN _0F,C $%0*% 1$) B,&$<*.0- $-0C*202 $%C #,2)0#$&*#7$.a$.*202

• /N _0F,C $%0*% 1$) B,&$<*.0- $-0C*202 $%C #,2)0#$&*#7

$-0C*202

• 5N _0F,C %*%+$%0*% 1$) B,&$<*.0- $-0C*202 $%C#,2)0#$&*#7 $.a$.*202



9%./ O

• 8 Xf 7,$# *.C B$., ;0&: $ :02&*#7 *M $.-*:*. $<(2, $%C

-0##:*202 )#,2,%&2 &* 5/ -W* kW` $%C $<C*B0%$. )$0%N

G, :$C <,,% C#0%a0%1 :,$]0.7 (%3. > C$7 )#0*# &*

)#,2,%&$3*% ;:,% <,-$(2, *M &:, $<C*B0%$. )$0% $%C

%$(2,$2 :, C02-*%3%(,C $.-*:*. -*%2(B)3*%N

• U% ,F$B :, $)),$#2 0..N

•

`'= I[ >>^We^ [ >^e @@ EX g Vf• 'a0%= Q u$(%C0-,4 2)0C,# &,.$%10,-&$20$2



9%./ O

• 6$<2=

• k$ >Ve T VNE L. i^ GLUV EV

• 8I" )G fNXf [LUE VV



9%./ O

c:$& 02 &:, $-0C <$2, C02&(#<$%-,

8N _,&$<*.0- 8-0C*202

IN @,2)0#$&*#7 8.a$.*202

LN

_,&$<*.0- 8-0C*202W@,2)0#$&*#7 8.a$.*202

/N _,&$<*.0- 8-0C*202W_,&$<*.0- 8.a$.*202W@,2)0#$&*#7

8.a$.*202

5N

L$% %*& 0%&,#)#,& C(, &* .$< ,##*#



9%./ T

•

8 VED7,$#D*.C B$% ;0&: $ :02&*#7 *M -:#*%0- $.-*:*.$<(2, )#,2,%&2 &* &:, 5B,#1,%-7 /,)$#&B,%&

-*%M(2,C $%C $10&$&,CN [:720-$. ,F$B #,],$.2

&,B),#$&(#, Vh* L4 )(.2, >>E <)B $%C <.**C

)#,22(#, >eXW>^^N G, 02 *#0,%&,C F >N 5F-,)& M*#

B0.C :,)$3- &,%C,#%,22 &:, #,B$0%C,# *M &:, ,F$B

02 %*#B$.N



9%./ T

8CB0220*% .$<2=

cIL >eN> :,B*1.*<0% >>NX ).$&,.,&2 >^h a

k$ >Ve T VNd L. >^X GLUV Ee Isk h

L#,$3%0%, >N^

G, 02 &#,$&,C ;0&: _`J $%C &:0$B0%, $%C $CB0b,C&* &:, JLs M*# 0B),%C0%1 /g2



9%./ T• g:, )$3,%& 02 &#,$&,C ;0&: J` .*#$A,)$B $%C #D

<.*-a,#2N I,-$(2, *M ;*#2,%0%1 $10&$3*% :02

.*#$A,)$B 02 3&#$&,C () <7 &:, %(#2,2N G, 02 $M,<#0.,

;0&: %*#B$. ]0&$. 201%2N U% C$7 X :02 .$<2 #,],$.=

• k$ >Vd T XN^ L. >^^ GLUV >d Isk h B1WC.

".(-*2, i^ B1WC.

• )G fNEi [LUE V^ GLUV >X

• ',#(B *2B*.$.0&7 VE^ B*2BWa1



9%./ T

c:$& 02 &:, .0a,.7 -$(2, *M :02 B,&$<*.0- $-0C*202t

8N /,.0#0(B &#,B,%2

IN 6*#$A,)$B C#0)

LN s%#,-*1%0A,C 2,)202

/N 60],# C02,$2,

5N [$%-#,$332



9%./ a

c:$& 02 H$#,? &:, $-0CD<$2, C02&(#<$%-,H2?t

8N _,&$<*.0- $-0C*202

IN _,&$<*.0- $.a$.*202

LN

_,&$<*.0- $-0C*202 ;0&: -*B),%2$&*#7 #,2)0#$&*#7$.a$.*202

/N _0F,C _,&$<*.0- 8-0C*202W @,2)0#$&*#7 8.a$.*202

5N

L$% %*& 0%&,#)#,& C(, &* .$< ,##*#



9%./ R

•

v*( $#, $2a,C &* ,]$.($&, $ eX 7W* B$., ;0&: $ :W*

LU[/ ;:* )#,2,%&,C X C$72 $1* ;0&: #,2)0#$&*#7

C02&#,22N G, ;$2 0%&(<$&,C $%C $CB0b,C &* &:, JLsN G5

:$2 <,,% &#,$&,C ;0&: 2*.(B,C#*.4 %,<(.0A,C $.<(&,#*.W0)#$&#*)0(B4 $%3<0*3-2 $%C 0%&#$],%*(2 M(#*2,B0C,N

• k$ >XX T VNE L. >^E GLUV Vh

•

8I" )G fNdh [LUE XE



9%./ R

c:$& 02 H$#,? &:, $-0CD<$2, C02*#C,#H2?

8N @,2)0#$&*#7 $-0C*202

IN _0F,C B,&$<*.0- $.a$.*202 $%C #,2)0#$&*#7 $-0C*202

LN

_0F,C B,&$<*.0- $.a$.*202 $%C #,2)0#$&*#7 $.a$.*202

/N _0F,C B,&$<*.0- $.a$.*202N _,&$<*.0- $-0C*202 $%C

#,2)0#$&*#7 $.a$.*202

5N

L$% %*& 0%&,#)#,& C(, &* .$< ,##*#



9%./ b

c:$& 02 &:, $-0C +<$2, C02&(#<$%-,

8N @,2)0#$&*#7 $-0C*202

IN @,2)0#$&*#7 $.a$.*202

LN

_0F,C #,2)0#$&*#7 $.a$.*202 $%C B,&$<*.0- $-0C*202

/N _0F,C #,2)0#$&*#7 $.a$.*2024 B,&$<*.0- $-0C*202 $%C

B,&$<*.0- $.a$.*202

5N

L$% %*& 0%&,#)#,& C(, &* .$< ,##*#



5DZZ%#@ $A </@ :$*>).

•

5]$.($3*% *M 8-0CDI$2, C02&(#<$%-,2

• g:*#*(1: Gx[

• _,$2(#,B,%& )G4 [LUE4 GLUV

•

L$.-(.$3*% -*##,-&,C 8%0*% "$)

• L$.-(.$3*% C,.&$WC,.&$

• s%C,#2&$%C0%1 -*B),%2$3*% #(.,2

` + + ` +* + !++*J 2



`/&$ZZ/>+/+ `/%+*>F %>+ !++*J$>%2

`/.$D#&/.

•

>? _,:&$ 8k $%C 5BB,b _N 8))#*$-: &* $-0CD<$2,

C02*#C,#2N J% [#0B,# *% T0C%,7 /02,$2,2N Hd&: ,C03*%?

"#,,%<,#1 8 H 5C?N '$(%C,#2 5.2,]0,#4 [:0.$C,.):0$ ))

ihD>^f4 E^^i•

E? 8%C#*1(, Gy4 ,&N $.N 822,220%1 $-0CD<$2, C02*#C,#2N

T0C%,7 J%&,#%$3*%$. fe=>EVi4 E^^i

• V? @*2, IN '0B)., $%C B0F,C $-0CD<$2, C02*#C,#N J%

s)g*/$&,



z(,23*%2t

acid-base disorder/ccm board review

Documents